Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Approximate doses per vial 40.0 doses Math reference only for in-vitro and laboratory research use
Retatrutide uniquely targets three nutrient-stimulated hormone receptors, providing the opportunity for additional improvements in health outcomes and potentially greater weight reduction, especially for those with severe obesity who may benefit from higher efficacy. Save the date Make plans to join us June 1821, 2027, for the 2027 Scientific Sessions at the Walter E
Recalls & Warnings April 11, 2008 Twelve Dietary Herbal Supplements Recalled -- Possible Health Risk Associated with Ephedra, Aristolochic Acid and Human Placenta On April 10, 2008, the FDA posted a recall notice issued the same day from Herbal Science International, Inc
As of 2022, it is included in WADAs prohibited substances list
